ConvaTec Group PLC (LON:CTEC) Given Average Recommendation of “Buy” by Brokerages

Shares of ConvaTec Group PLC (LON:CTEC) have been assigned an average recommendation of “Buy” from the eight analysts that are covering the stock, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have issued a report on the stock in the last year is GBX 319.

CTEC has been the subject of several research analyst reports. Stifel Nicolaus reissued a “buy” rating and set a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday, March 11th. Citigroup reaffirmed an “outperform” rating and issued a GBX 315 target price on shares of ConvaTec Group in a report on Thursday, March 5th. Finally, Berenberg Bank lifted their price target on ConvaTec Group from GBX 330 to GBX 340 and gave the stock a “buy” rating in a research report on Thursday, January 22nd.

Insider Activity

In related news, insider Jonny Mason sold 291,149 shares of the business’s stock in a transaction on Monday, March 16th. The shares were sold at an average price of GBX 234, for a total transaction of £681,288.66. Insiders own 0.95% of the company’s stock.

ConvaTec Group Stock Down 3.3%

CTEC stock opened at GBX 226.20 on Thursday. The stock has a market capitalization of £4.41 billion, a price-to-earnings ratio of 26.30, a price-to-earnings-growth ratio of 0.93 and a beta of 0.76. The company has a 50-day moving average of GBX 235.12 and a two-hundred day moving average of GBX 236.66. ConvaTec Group has a 52-week low of GBX 209.40 and a 52-week high of GBX 311.20. The company has a debt-to-equity ratio of 106.19, a current ratio of 1.53 and a quick ratio of 0.96.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.